Purdue Pharmaceutical Products L.P.
Records under this name other than the patents Purdue Pharmaceutical Products L.P. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Back to Purdue Pharmaceutical Products L.P.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,063,203 | Compositions and Methods of Making a Photoactive Agent now held by Light Sciences Oncology Inc. In force · High confidence | In force | High confidence | |
| US 8,822,677 | Compositions and Methods of Making a Photoactive Agent now held by Light Sciences Oncology Inc. In force · High confidence | In force | High confidence | |
| US 8,198,312 | Compositions and Methods of Making a Photoactive Agent now held by Light Sciences Oncology Inc. In force · High confidence | In force | High confidence | |
| US RE46,144 | Hydroxamic Acid Derivatives now held by Knoa Pharmaceutical Products LLC In force · Low confidence | In force | Low confidence | |
| US RE46,504 | Light Delivery System now held by Light Sciences Oncology Inc. In force · Low confidence | In force | Low confidence | |
| US RE47,491 | Light Transmission System for Photoreactive Therapy now held by Light Sciences Oncology Inc. In force · Low confidence | In force | Low confidence | |
| US 11,419,853 | Compounds for Treating Brain Cancer now held by Knoa Pharma LLC In force · High confidence | In force | High confidence | |
| US 12,370,177 | Compounds for Treating Brain Cancer now held by Knoa Pharma LLC In force · High confidence | In force | High confidence | |
| US 12,403,130 | Pharmaceutical Combinations for Treating Cancer now held by Knoa Pharma LLC In force · High confidence | In force | High confidence | |
| US 9,993,482 | Pharmaceutical Combination Comprising a Class III Receptor Tyrosine Kinase Inhibitor and the Alkylating Histone-Deacetylase Inhibitor Fusion Molecule EDO-S101 Together with Its Use in the Treatment of Cancer now held by Knoa Pharma LLC In force · High confidence | In force | High confidence |